Double-blind, placebo-controlled randomized trial with adalimumab for treatment of juvenile onset ankylosing spondylitis (JoAS): significant short term improvement.

Arthritis Res Ther · 2012 · PMC3580542 · PMID 23095307

Europe PMC DOI

hedged sentences

0.0540

closest p · 1.1× alpha

0.0540

boldest claim

The sentences

nearly significantP = 0.054so close (0.05 < p ≤ 0.1)

The course of CHAQ showed nearly significant differences in favor of adalimumab at week 8 ( P = 0.054).

also in 3,349 other papers

only marginally significantno p-value reported

In a clinical trial on polyarticular JIA, the effect on joint tenderness, joint swelling, joint score and laboratory parameters was only marginally significant [ 38 ].

also in 5,085 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.